Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus
Koon-Hou Mak, MBBS* and
Eric J. Topol, MD
* Department of Cardiology, National Heart Centre, Singapore
Department of Cardiology, Joseph J. Jacobs for Thrombosis and Vascular Biology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA

View larger version (23K):
[in a new window]
|
Figure 1 Kaplan-Meier estimates of cumulative mortality by diabetes status in the GUSTO-I Study (3).
|
|

View larger version (17K):
[in a new window]
|
Figure 2 Odds ratio in a multiple logistic regression model for predicting the use of fibrinolysis in the SAVE Trial. SAVE = Survival and Ventricular Enlargement Study.
|
|

View larger version (17K):
[in a new window]
|
Figure 3 In-hospital angiographic reocclusion and 30-day reinfarction rates after fibrinolysis in the GUSTO-I Study.
|
|
Copyright © 2000 by the American College of Cardiology Foundation.